Literature DB >> 32076665

Sexual Dimorphism of Coronary Artery Disease in a Low- and Intermediate-Risk Asymptomatic Population: Association with Coronary Vessel Wall Thickness at MRI in Women.

Ahmed M Ghanem1, Jatin Raj Matta1, Reham Elgarf1, Ahmed Hamimi1, Ranganath Muniyappa1, Hadjira Ishaq1, Colleen Hadigan1, Michael V McConnell1, Ahmed M Gharib1, Khaled Z Abd-Elmoniem1.   

Abstract

PURPOSE: To demonstrate the association between coronary vessel wall thickness (VWT) measured at MRI and coronary artery disease (CAD) risk in asymptomatic groups at low and intermediate risk on the basis of Framingham score.
MATERIALS AND METHODS: A total of 131 asymptomatic adults were prospectively enrolled. All participants underwent CT angiography for scoring CAD, and coronary VWT was measured at 3.0-T MRI. Nonlinear single and multivariable regression analyses with consideration for interaction with sex were performed to investigate the association of traditional atherosclerotic risk factors and VWT with CT angiography-based CAD scores.
RESULTS: The analysis included 62 women and 62 men with low or intermediate Framingham score of less than 20%. Age (mean age, 45.0 years ± 14.5 [standard deviation]) and body mass index were not different between the groups. Age, sex, and VWT were individually significantly associated with all CT angiography-based CAD scores (P < .05). Additionally, sex was a significant effect modifier of the associations with all CAD scores. In men, age was the only statistically significant independent risk factor of CAD; in women, VWT was the only statistically significant independent surrogate associated with increased CAD scores (P < .05).
CONCLUSION: In asymptomatic women, VWT MRI was the primary independent surrogate of CAD, whereas age was the strongest risk factor in men. This study suggests that VWT may be used as a CAD surrogate in women at low or intermediate risk of CAD. Further longitudinal studies are required to determine the potential implication and use of this MRI technique for the preventative management of CAD in women.© RSNA, 2019. 2019 by the Radiological Society of North America, Inc.

Entities:  

Year:  2019        PMID: 32076665      PMCID: PMC6555440          DOI: 10.1148/ryct.2019180007

Source DB:  PubMed          Journal:  Radiol Cardiothorac Imaging        ISSN: 2638-6135


  40 in total

1.  Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease.

Authors:  W Yong Kim; Matthias Stuber; Peter Börnert; Kraig V Kissinger; Warren J Manning; René M Botnar
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

2.  Arterial wall imaging: evaluation with 16-section multidetector CT in blood vessel phantoms and ex vivo coronary arteries.

Authors:  Maros Ferencik; Raymond C Chan; Stephan Achenbach; Jennifer B Lisauskas; Stuart L Houser; Udo Hoffmann; Suhny Abbara; Ricardo C Cury; Brett E Bouma; Guillermo J Tearney; Thomas J Brady
Journal:  Radiology       Date:  2006-07-20       Impact factor: 11.105

3.  Much ado about nothing: A comparison of missing data methods and software to fit incomplete data regression models.

Authors:  Nicholas J Horton; Ken P Kleinman
Journal:  Am Stat       Date:  2007-02       Impact factor: 8.710

4.  ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance.

Authors:  Allen J Taylor; Manuel Cerqueira; John McB Hodgson; Daniel Mark; James Min; Patrick O'Gara; Geoffrey D Rubin
Journal:  J Cardiovasc Comput Tomogr       Date:  2010-11-23

5.  Sex differences in mortality associated with computed tomographic angiographic measurements of obstructive and nonobstructive coronary artery disease: an exploratory analysis.

Authors:  Leslee J Shaw; James K Min; Jagat Narula; Fay Lin; C Noel Bairey-Merz; Tracy Q Callister; Daniel S Berman
Journal:  Circ Cardiovasc Imaging       Date:  2010-05-19       Impact factor: 7.792

6.  Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy.

Authors:  Won Yong Kim; Anne Sofie Astrup; Matthias Stuber; Lise Tarnow; Erling Falk; René M Botnar; Cheryl Simonsen; Lotte Pietraszek; Peter R Hansen; Warren J Manning; Niels T Andersen; Hans-Henrik Parving
Journal:  Circulation       Date:  2006-12-26       Impact factor: 29.690

Review 7.  Cardiac syndrome X and microvascular coronary dysfunction.

Authors:  Erika Jones; Wafia Eteiba; Noel Bairey Merz
Journal:  Trends Cardiovasc Med       Date:  2012-09-29       Impact factor: 6.677

8.  Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines.

Authors:  Khurram Nasir; Erin D Michos; Roger S Blumenthal; Paolo Raggi
Journal:  J Am Coll Cardiol       Date:  2005-10-20       Impact factor: 24.094

9.  Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease.

Authors:  Bong-Ki Lee; Hong-Seok Lim; William F Fearon; Andy S Yong; Ryotaro Yamada; Shigemitsu Tanaka; David P Lee; Alan C Yeung; Jennifer A Tremmel
Journal:  Circulation       Date:  2015-02-20       Impact factor: 29.690

10.  An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Matheen A Khuddus; Carl J Pepine; Eileen M Handberg; C Noel Bairey Merz; George Sopko; Anthony A Bavry; Scott J Denardo; Susan P McGorray; Karen M Smith; Barry L Sharaf; Steven J Nicholls; Steven E Nissen; R David Anderson
Journal:  J Interv Cardiol       Date:  2010-10-04       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.